Procter & Gamble Health Ltd. is in Pharmaceuticals & Drugs. It was incorporated in year 1967. The current market capitalisation stands Rs 7781 Cr. The company is listed on the Bombay Stock Exchange (BSE) with the BSE code as 500126. and also listed on National Stock Exchange (NSE) with NSE code as PGHL.
Merck Limited manufactures and markets pharmaceuticals and chemicals in India. The Pharmaceuticals segment offers multi-vitamin products under the Evion, Neurobion, and Polybion brands; cardio-vascular care products under the Concor brand; Carbophage branded products to treat metabolic disorders; Livogen branded products for haematinics; and Immubron and Pedimune branded Immuno-stimulators. It also provides consumer health care products, including vitamin B, cough and cold, and other consumer health products under the Nasivion, Seven Seas Original, Maxepa, Electrobion, and Evion Cream brands. In addition, this segment exports its products to Asian and African countries, including Sri Lanka, Bangladesh, Myanmar, Maldives, Austria, and Kenya. The Chemicals segment offers active pharmaceutical ingredients, excipients, and bio-pharmaceutical process chemicals for pharma and biopharma industries; and effect pigments and functional materials for the automotive, cosmetics, plastics printing, and security industries. The was formerly known as E. Merck Limited The was founded in 1967 and is headquartered in Mumbai, India. As of December 1, 2018, Merck Limited operates as a subsidiary of Procter and Gamble Overseas India B.V.
Mutual fund investments are subject to market risks. Please read the scheme information and other related documents carefully before investing.
Past performance is not indicative of future returns. Please consider your specific investment requirements, risk tolerance, investment goal, time frame, risk and reward balance and the cost associated with the investment before choosing a fund, or designing a portfolio that suits your needs.